Erschienen in:
01.02.2009 | Original Paper
Non-invasive coronary angiography: the clinical value of multi-slice computed tomography in the assessment of patients with prior coronary bypass surgery
Evaluating grafts and native vessels
verfasst von:
Helge von Kiedrowski, Marcus Wiemer, Krista Franzke, Rainer Preuss, Bernhard Vaske, Thomas Butz, Olaf Oldenburg, Thomas Bitter, Khalid Mahmood, Wolfram Burchert, Dieter Horstkotte, Christoph Langer
Erschienen in:
The International Journal of Cardiovascular Imaging
|
Ausgabe 2/2009
Einloggen, um Zugang zu erhalten
Abstract
Background Contrast enhanced multi-slice computed tomography (MSCT) is the leading modality in non-invasive coronary angiography (CTA) today. We investigated MSCT based assessment of coronary artery bypass grafts (CABG) by analyzing assets and drawbacks of CTA in order to define demands on latest technology. Methods In a clinical setting 39 CABG patients (69.2 ± 1.4 years; male n = 36) underwent CTA (collimation 16 × 0.75 mm, contrast medium 100 ml; 320 mAs, 120 KV). Ninety-seven CABG (61 venous, 36 arterial grafts) were evaluated. A subgroup of 18 patients underwent additional invasive coronary angiography (CA). Results CTA for CABG assessment resulted in an overall sensitivity (sens.) of 100%, specificity (spec.) of 92.4% and positive and negative predictive values (PPV, NPV) of 60% and 100%, respectively. CABG anastomoses showed slightly inferior diagnostic accuracy than other CABG segments. Limitations in imaging quality caused 21% unevaluable segments of the CABG anastomoses. Evaluation of native vessel segments proximal and distal to the anastomoses resulted in a sens, spec, PPV and NPV of 57.5, 94.6, 92 and 67.3%, respectively. With 28.5% unevaluable segments, the native vessel segments showed serious limitations in imaging quality. Radiation exposure was 9.88 ± 3.20 mSv (9.69 ± 3.25 mSv male; 12.08 ± 1.35 mSv female). Conclusion 16-slice MSCT based CABG assessment offers sufficient diagnostic accuracy. However, focussing on the bypass anastomoses and the native revascularized coronary arteries, clinical value is limited.